April 02, 2015 09:15 ET

SOHM Signs Private Label Contract Manufacturing Agreement for Nutraceutical Products

CORONA, CA--(Marketwired - Apr 2, 2015) - SOHM, Inc. (OTC PINK: SHMN), a manufacturer of generic Pharmaceutical, Nutraceutical and Cosmeceutical products, announced today they have signed private label contract manufacturing for their Nutraceutical units.

Shailesh Shah, President and CEO, announced today that SOHM India has signed a private label contract manufacturing agreement with one of pharmaceutical company based at India for their 10 nutraceutical products. Mr. Shah states that this opportunity will significantly help the company generate revenues in coming quarters and also increase its plant utilization in more meaningful yields.

Food and dietary supplements, vitamin and nutraceuticals witnessed a value CAGR at constant 2013 prices of 9% during the forecast period of 2013-2018. Growth is expected to be driven by natural and traditional supplements. It is estimated that Indian nutraceutical markets value growth to reach almost $2700 million by year 2016.

SOHM looks to continue their current product lines and have a continued encouraging response from consumers during the past years. Mr. Shah states that this development should help company go beyond its current revenues and profitability during 2015.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Besides generic drugs, SOHM also has manufacturing facilities for food supplements and cosmetics. The Company has global headquarters located in California, U.S., with manufacturing facilities in India. SOHM exports generic pharmaceuticals worldwide, placing a heavy focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. For more information visit the company's website at:

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • SOHM, Inc.
    Investor Relations